Siga Technologies (SIGA) Other Non Operating Income (2020)
Siga Technologies' (SIGA) quarterly Other Non Operating Income came in at $18539.0 in Q4 2020, up 100.37% quarter-over-quarter from -$5.0 million in Q1 2020.
Powered by 
Analysis
Siga Technologies (SIGA) Other Non Operating Income (2020) Analysis & Trends
Siga Technologies (SIGA) has reported Other Non Operating Income for 1 consecutive years, with $18539.0 the latest figure, recorded in Q4 2020.
- For the quarter ending Q4 2020, Other Non Operating Income changed N/A year-over-year to $18539.0; the trailing twelve-month figure through Sep 2021 stood at $18539.0 (up 100.37% YoY), and the FY2020 full-year result was -$5.0 million, changed N/A from the prior year.
- Other Non Operating Income climbed to $18539.0 in Q4 2020 per SIGA's latest filing, from -$5.0 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $18539.0 in Q4 2020 and bottomed at -$5.0 million in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - |